IL23668A - Crystalline nitrofuranthoin and processes for its preparation - Google Patents

Crystalline nitrofuranthoin and processes for its preparation

Info

Publication number: IL23668A
Authority: IL; Israel
Prior art keywords: nitrofurantoin; mesh; crystals; preparation; crystalline
Prior art date: 1964-08-25

Application number

IL23668A

Other languages

English (en)

Original Assignee

Norwich Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1964-08-25

Filing date

1965-06-03

Publication date

1969-07-30

1965-06-03 Application filed by Norwich Pharma Co filed Critical Norwich Pharma Co

1969-07-30 Publication of IL23668A publication Critical patent/IL23668A/en

Links

238000000034 method Methods 0.000 title claims description 4
229960000564 nitrofurantoin Drugs 0.000 claims description 12
NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 claims description 12
239000013078 crystal Substances 0.000 claims description 11
238000012216 screening Methods 0.000 claims 2
101100512897 Caenorhabditis elegans mes-2 gene Proteins 0.000 claims 1
239000008194 pharmaceutical composition Substances 0.000 claims 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
206010028813 Nausea Diseases 0.000 description 2
206010047700 Vomiting Diseases 0.000 description 2
239000000463 material Substances 0.000 description 2
230000008693 nausea Effects 0.000 description 2
230000002485 urinary effect Effects 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
238000013019 agitation Methods 0.000 description 1
238000003556 assay Methods 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
239000002775 capsule Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
238000004821 distillation Methods 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000002895 emetic Substances 0.000 description 1
230000000763 evoking effect Effects 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
238000009738 saturating Methods 0.000 description 1
CMXPERZAMAQXSF-UHFFFAOYSA-M sodium;1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate;1,8-dihydroxyanthracene-9,10-dione Chemical compound [Na+].O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O.CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC CMXPERZAMAQXSF-UHFFFAOYSA-M 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000009974 thixotropic effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

IL23668A 1964-08-25 1965-06-03 Crystalline nitrofuranthoin and processes for its preparation IL23668A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US392023A US3401221A (en)	1964-08-25	1964-08-25	Treatment of urinary tract infection

Publications (1)

Publication Number	Publication Date
IL23668A true IL23668A (en)	1969-07-30

Family

ID=23548942

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL23668A IL23668A (en)	1964-08-25	1965-06-03	Crystalline nitrofuranthoin and processes for its preparation

Country Status (14)

Country	Link
US (1)	US3401221A (fr)
JP (1)	JPS4924651B1 (fr)
AT (1)	AT261117B (fr)
BE (1)	BE668774A (fr)
DE (1)	DE1492055B1 (fr)
DK (1)	DK116132B (fr)
ES (1)	ES313664A1 (fr)
FI (1)	FI42961B (fr)
FR (1)	FR4844M (fr)
GB (1)	GB1040980A (fr)
IL (1)	IL23668A (fr)
NL (1)	NL6506369A (fr)
NO (1)	NO118491B (fr)
SE (1)	SE326186B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2348334C2 (de) *	1973-09-26	1982-11-11	Boehringer Mannheim Gmbh, 6800 Mannheim	Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
DE3033919A1 (de) *	1980-09-09	1982-04-22	Bayer Ag, 5090 Leverkusen	Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
US4798725A (en) *	1986-06-16	1989-01-17	Norwich Eaton Pharmaceuticals, Inc.	Sustained release capsule
US4772473A (en) *	1986-06-16	1988-09-20	Norwich Eaton Pharmaceuticals, Inc.	Nitrofurantoin dosage form
US5178880A (en) *	1989-07-25	1993-01-12	Norwich Eaton Pharmaceuticals, Inc.	Liquid suspensions of nitrofurantoin
US5332832A (en) *	1989-07-26	1994-07-26	Procter & Gamble Pharmaceuticals, Inc.	Nitrofurantoin crystals
WO2004017938A2 (fr) *	2002-08-23	2004-03-04	Ranbaxy Laboratories Limited	Forme galenique a liberation controlee de nitrofurantoine

1964
- 1964-08-25 US US392023A patent/US3401221A/en not_active Expired - Lifetime
1965
- 1965-05-19 NL NL6506369A patent/NL6506369A/xx unknown
- 1965-05-25 DE DE19651492055 patent/DE1492055B1/de active Pending
- 1965-06-01 ES ES0313664A patent/ES313664A1/es not_active Expired
- 1965-06-03 IL IL23668A patent/IL23668A/en unknown
- 1965-06-16 SE SE07949/65A patent/SE326186B/xx unknown
- 1965-06-22 DK DK316165AA patent/DK116132B/da unknown
- 1965-07-19 NO NO159004A patent/NO118491B/no unknown
- 1965-07-21 JP JP40043717A patent/JPS4924651B1/ja active Pending
- 1965-08-05 FR FR27293A patent/FR4844M/fr not_active Expired
- 1965-08-09 GB GB34070/65A patent/GB1040980A/en not_active Expired
- 1965-08-18 FI FI1983/65A patent/FI42961B/fi active
- 1965-08-24 AT AT774865A patent/AT261117B/de active
- 1965-08-25 BE BE668774D patent/BE668774A/xx unknown

Also Published As

Publication number	Publication date
US3401221A (en)	1968-09-10
JPS4924651B1 (fr)	1974-06-25
AT261117B (de)	1968-04-10
ES313664A1 (es)	1965-09-01
FI42961B (fr)	1970-09-02
NL6506369A (fr)	1966-02-28
DE1492055B1 (de)	1971-05-13
FR4844M (fr)	1967-02-20
BE668774A (fr)	1965-12-16
DK116132B (da)	1969-12-15
NO118491B (fr)	1970-01-05
SE326186B (fr)	1970-07-20
GB1040980A (en)	1966-09-01

Similar Documents

Publication	Publication Date	Title
SE455469B (sv)	1988-07-18	Farmaceutisk komposition innehallande stabil, mikrokristallin cis-platina (ii)-diammindiklorid
CZ301778B6 (cs)	2010-06-23	Modifikace 2-amino-4-(4-fluorbenzylamino)-1-ethoxykarbonylaminobenzenu, zpusoby jejich prípravy, jejich použití a lécivo, které je obsahuje
IL23668A (en)	1969-07-30	Crystalline nitrofuranthoin and processes for its preparation
EP0212537B1 (fr)	1990-01-03	Procédé pour la préparation d'une modification stable de torasémide ainsi que médicaments le contenant
EP0239172B1 (fr)	1993-02-24	Lactose séché par pulvérisation de qualité améliorée et son procédé de préparation
IE914316A1 (en)	1992-06-17	Heterocyclic compounds
Beals et al.	1965	The ultrastructure of human testicular tumors. I. Interstitial cell tumors
KR100993487B1 (ko)	2010-11-10	카랄루마 추출물의 제조방법 및 사용
DE69417490T2 (de)	1999-09-23	Feste Formulierung
EP2418954B1 (fr)	2013-05-29	Co-cristal comprenant de l'imidaclopride et son procédé de fabrication
Mupparaju et al.	2019	Formulation and evaluation of dolutegravir sodium solid dispersions and fast dissolving tablets using poloxamer-188 and jackfruit seed starch as excipients
DE69808721T2 (de)	2003-06-12	Stabile, trockene herbizide Zusammensetzungen
EP0357967B1 (fr)	1992-12-02	Phyto- et zoostérols et leurs dérivés solubles dans l'eau
Howell et al.	1971	Somatic chromosomes of the lamprey, Ichthyomyzon gagei (Agnatha: Petromyzonidae)
US2441163A (en)	1948-05-11	Treatment of pineapple plants with plant hormones
RU2024495C1 (ru)	1994-12-15	Способ кристаллизации октогена
Moews et al.	1972	X-ray crystallographic study of the rennin-like enzyme of Mucor pusillus var. lindt
Nene et al.	1966	Control of stem-gall of coriander by fungicides
US2730449A (en)	1956-01-10	Processes for the preparation of inoculating materials for concentrated milk products and for improving the crystallization of lactose in concentrated milk products
RU1771638C (ru)	1992-10-30	Способ защиты сельскохоз йственных культур от остатков пестицидов в почве
US2428335A (en)	1947-09-30	Culture of pineapple plants
US3820973A (en)	1974-06-28	Method and composition for the stimulation of plant growth
FEIGELSON	1989	Protein crystal growth in low gravity(Semiannual Technical Report, 27 Apr.- 26 Oct.)(1989)
Thaganov et al.	2024	Methods of increasing herbage yield and seed productivity of Echinacea purpurea under conditions of Krasnodar krai
ELBAN et al.	1984	Microstructural origins of hot spots in RDX explosive and a reference inert material[Annual Progress Report, 1 Oct. 1982- 30 Sep. 1983]